Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Top Cited Papers
Open Access
- 1 April 2013
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 138 (1), 103-141
- https://doi.org/10.1016/j.pharmthera.2012.12.007
Abstract
No abstract availableKeywords
Funding Information
- Robert Bosch Stiftung
- Deutsche Forschungsgemeinschaft (SCHW 858/1-1)
- Bundesministerium für Bildung und Forschung (03 IS 2061C, 0315755)
- Seventh Framework Programme (PITN-GA-2009-238132)
This publication has 426 references indexed in Scilit:
- Meta-Analysis of Cytochrome P450 2C19 Polymorphism and Risk of Adverse Clinical Outcomes Among Coronary Artery Disease Patients of Different Ethnic Groups Treated With ClopidogrelThe American Journal of Cardiology, 2012
- Bupropion metabolism by human placentaBiochemical Pharmacology, 2010
- Analysis of humanCYP1A1andCYP1A2genes and their shared bidirectional promoter in eight world populationsHuman Mutation, 2009
- microRNA miR-27b impairs human adipocyte differentiation and targets PPARγBiochemical and Biophysical Research Communications, 2009
- CYP2E1 and oxidative liver injury by alcoholFree Radical Biology & Medicine, 2008
- Regulation of CYP3A4 and CYP2B6 expression by liver X receptor agonistsBiochemical Pharmacology, 2007
- Selective, competitive and mechanism-based inhibitors of human cytochrome P450 2J2Archives of Biochemistry and Biophysics, 2007
- CAR and PXR: The xenobiotic-sensing receptorsSteroids, 2007
- The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expressionPharmacology & Therapeutics, 2007
- A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressantsClinical Pharmacology & Therapeutics, 2006